HHCP
COGT icon

Hilton Head Capital Partners’s Cogent Biosciences COGT Stock Holding History

Hilton Head Capital Partners’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.74K Sell
200
-332
-62% -$11.6K ﹤0.01% 618
2026
Q1 		$20.5K Buy
532
+200
+60% +$7.38K 0.01% 472
2025
Q4 		$11.8K Buy
+332
New +$9.33K 0.01% 544

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Hilton Head Capital Partners's COGT Position: Q2 2026 in Review

Hilton Head Capital Partners reduced its Cogent Biosciences (COGT) stake by 62% in Q2 2026, selling an estimated $11.6K and leaving 200 shares worth $7.74K. The position accounts for ﹤0.01% of the portfolio, ranked #618.

Hilton Head Capital Partners first reported a position in COGT in Q4 2025 and has held it in 3 quarters since. The position peaked at $20.5K in Q1 2026. 322 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Hilton Head Capital Partners held 200 shares of Cogent Biosciences worth $7.74K as of Q2 2026.
  • Hilton Head Capital Partners sold 332 Cogent Biosciences shares in Q2 2026, an estimated $11.6K.
  • Cogent Biosciences made up ﹤0.01% of Hilton Head Capital Partners's portfolio in Q2 2026, its #618 holding.
  • Hilton Head Capital Partners first reported a position in Cogent Biosciences in Q4 2025 and has held it in 3 quarters since.
  • Hilton Head Capital Partners's Cogent Biosciences position peaked at $20.5K in Q1 2026.
  • 322 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Hilton Head Capital Partners's 13F filing for Q2 2026, filed 27 Jul 2026.